Brolucizumab: A Newly Developed Anti-VEGF Molecule for the Treatment of Neovascular Age-Related Macular Degeneration

Autoren

Tadayoni R, Sararols L, Weissgerber G, Verma R, Clemens A (co-senior authorship)

Abstract